| Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein S Tarapcsák, G Szalóki, Á Telbisz, Z Gyöngy, K Matúz, É Csősz, P Nagy, ... Scientific reports 7 (1), 41376, 2017 | 31 | 2017 |
| Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases T Sperka, G Miklossy, Y Tie, P Bagossi, G Zahuczky, P Boross, K Matuz, ... Journal of general virology 88 (7), 2052-2063, 2007 | 29 | 2007 |
| Inhibition of XMRV and HIV‐1 proteases by pepstatin A and acetyl‐pepstatin K Matúz, J Mótyán, M Li, A Wlodawer, J Tőzsér The FEBS journal 279 (17), 3276-3286, 2012 | 21 | 2012 |
| C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity J Kádas, P Boross, IT Weber, P Bagossi, K Matúz, J Tözsér Biochemical Journal 416 (3), 357-364, 2008 | 18 | 2008 |
| Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus‐related virus protease M Li, A Gustchina, K Matúz, J Tözsér, S Namwong, NE Goldfarb, BM Dunn, ... The FEBS journal 278 (22), 4413-4424, 2011 | 16 | 2011 |
| Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease JM Louis, J Tözsér, J Roche, K Matúz, A Aniana, JM Sayer Biochemistry 52 (43), 7678-7688, 2013 | 14 | 2013 |
| Biochemical characterization, specificity and inhibition studies of HTLV-1, HTLV-2, and HTLV-3 proteases N Kassay, JA Mótyán, K Matúz, M Golda, J Tőzsér Life 11 (2), 127, 2021 | 10 | 2021 |
| A modular system to evaluate the efficacy of protease inhibitors against HIV-2 M Mahdi, K Matúz, F Tóth, J Tőzsér PLoS One 9 (11), e113221, 2014 | 10 | 2014 |
| Biochemical characterization of human retroviral-like aspartic protease 1 (ASPRV1) M Golda, JA Mótyán, K Nagy, K Matúz, T Nagy, J Tőzsér Biomolecules 10 (7), 1004, 2020 | 7 | 2020 |
| Goldfarb, NE, Dunn,. B. N. and Wlodawer, A.(2011). Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease M Li, A Gustchina, K Matúz, J Tözsér, S Namwong FEBS Lett 278 (22), 4413-24, 0 | 4 | |
| Different mutation tolerance of Lentiviral (HIV-1) and deltaretroviral (BLV and HTLV) protease precursors JA Mótyán, N Kassay, K Matúz, J Tőzsér Viruses 14 (9), 1888, 2022 | 2 | 2022 |
| Bovine Leukemia Virus Retropepsin T Sperka, K Matúz, J Tözsér Handbook of Proteolytic Enzymes, 218-220, 2013 | 1 | 2013 |
| A xenotróp egér leukémia vírussal rokon vírus (XMRV) proteáz biokémiai karakterizálása K Matúz | | 2013 |
| A retrovirális proteázok szerepének vizsgálata a retrovírusok életciklusának korai fázisában= Studies on the retroviral protease in the early phase of life-cycle J Tőzsér, P Bagossi, P Bander, P Boross, H Eizert, K Matúz, G Miklóssy, ... OTKA Kutatási Jelentések| OTKA Research Reports, 2012 | | 2012 |
| Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein Running title: Interactions of retinoids with ABCB1 and ABCG2 S Tarapcsák, G Szalóki, Á Telbisz, Z Gyöngy, K Matúz, É Csősz, P Nagy, ... | | |
